台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    60.0
  • 漲跌
    ▲0.2
  • 漲幅
    +0.33%
  • 成交量
    11
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智基 (6294)籌碼相關-富邦-公益 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-公益 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/180.161.0000.0061.100.1910.11%
2024/12/030.165.0000.0065.600.1970.10%
2024/11/200.266.2000.0064.400.2910.22%
2024/11/1400.00673.8569.70-6102-5.83%
2024/11/1300.000.478.5077.40-0.497-0.41%
2024/11/120.286.0000.0086.000.2900.22%
2024/10/170.197.0000.0096.800.11370.07%
2024/10/160.196.9000.0096.900.11370.07%
2024/09/060.199.90199.6099.50-0.9137-0.66%
2024/09/020.1101.0000.00100.500.11390.07%
2024/08/300101.0000.00101.0001390.01%
2024/08/290.1101.0000.00101.000.11380.07%
2024/08/2600.001101.00101.00-1137-0.73%
2024/08/201105.000.1105.50104.500.91330.68%
2024/08/131103.0000.00101.5011090.92%
2024/08/0800.000105.50105.00095-0.01%
2024/08/053100.0000.0098.803893.34%
2024/08/021100.5000.00100.501881.13%
2024/07/311100.0000.00100.001891.12%
2024/07/290.1101.0000.00100.500.1890.08%
2024/07/161102.4900.00102.001911.12%
2024/07/150101.5000.00101.500920.01%
2024/07/091101.0200.00101.5011011.02%
2024/07/050.1102.0000.00102.000.11090.05%
2024/07/040.2102.0000.00102.500.21280.16%
2024/06/251101.0000.00101.0011370.73%
2024/06/130.2101.0000.00100.500.21520.10%
2024/05/2900.004.7102.57102.50-4.7159-2.92%
2024/05/2400.001102.50103.00-1157-0.63%
2024/05/210.1103.0000.00102.000.11550.06%
2024/05/201105.0000.00103.5011540.65%
2024/05/1600.000107.00107.000150-0.01%
2024/05/150.4103.0000.00104.000.41480.24%
2024/05/140103.0000.00102.0001440.01%
2024/05/131.3107.001.2107.03107.000.11270.08%
2024/05/073.2119.0600.00119.503.21192.69%
2024/05/0300.000.1118.50118.50-0.1117-0.04%
2024/04/250.2117.5000.00117.500.21150.18%
2024/04/1900.000.1116.00116.00-0.1113-0.09%
2024/04/031123.5000.00123.501711.40%
2024/03/270.1122.5000.00122.000.1660.08%
2024/03/1500.000.1121.00121.50-0.147-0.21%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音